1771 related articles for article (PubMed ID: 19702903)
1. Prevention of hepatocellular carcinoma in hepatitis B virus infection.
Lim SG; Mohammed R; Yuen MF; Kao JH
J Gastroenterol Hepatol; 2009 Aug; 24(8):1352-7. PubMed ID: 19702903
[TBL] [Abstract][Full Text] [Related]
2. Treatment of chronic hepatitis B: Evolution over two decades.
Yuen MF; Lai CL
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():138-43. PubMed ID: 21199525
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of hepatitis B-related liver cirrhosis in the era of oral nucleos(t)ide analog antiviral agents.
Kim CH; Um SH; Seo YS; Jung JY; Kim JD; Yim HJ; Keum B; Kim YS; Jeen YT; Lee HS; Chun HJ; Kim CD; Ryu HS
J Gastroenterol Hepatol; 2012 Oct; 27(10):1589-95. PubMed ID: 22554121
[TBL] [Abstract][Full Text] [Related]
4. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.
Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma
J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323
[TBL] [Abstract][Full Text] [Related]
5. Management of chronic hepatitis B infection.
Sundaram V; Kowdley K
BMJ; 2015 Oct; 351():h4263. PubMed ID: 26491030
[TBL] [Abstract][Full Text] [Related]
6. [Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis].
Schott E; Bergk A; Berg T
Z Gastroenterol; 2008 Jan; 46(1):69-80. PubMed ID: 18188819
[TBL] [Abstract][Full Text] [Related]
7. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus: from diagnosis to treatment.
Dény P; Zoulim F
Pathol Biol (Paris); 2010 Aug; 58(4):245-53. PubMed ID: 20580167
[TBL] [Abstract][Full Text] [Related]
9. Risk assessment for the development of hepatocellular carcinoma: according to on-treatment viral response during long-term lamivudine therapy in hepatitis B virus-related liver disease.
Eun JR; Lee HJ; Kim TN; Lee KS
J Hepatol; 2010 Jul; 53(1):118-25. PubMed ID: 20471129
[TBL] [Abstract][Full Text] [Related]
10. Prevention and surveillance of hepatitis B virus-related hepatocellular carcinoma.
Liaw YF
Semin Liver Dis; 2005; 25 Suppl 1():40-7. PubMed ID: 16103980
[TBL] [Abstract][Full Text] [Related]
11. Chronic hepatitis B in Asia-new insights from the past decade.
Chan HL; Jia J
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():131-7. PubMed ID: 21199524
[TBL] [Abstract][Full Text] [Related]
12. Prevention of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
Kim BK; Han KH; Ahn SH
Oncology; 2011; 81 Suppl 1():41-9. PubMed ID: 22212935
[TBL] [Abstract][Full Text] [Related]
13. The clinical implications of hepatitis B virus genotype: Recent advances.
Lin CL; Kao JH
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():123-30. PubMed ID: 21199523
[TBL] [Abstract][Full Text] [Related]
14. A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
Goldstein ST; Zhou F; Hadler SC; Bell BP; Mast EE; Margolis HS
Int J Epidemiol; 2005 Dec; 34(6):1329-39. PubMed ID: 16249217
[TBL] [Abstract][Full Text] [Related]
15. Does antiviral therapy prevent hepatocellular carcinoma?
Kwon H; Lok AS
Antivir Ther; 2011; 16(6):787-95. PubMed ID: 21900710
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma.
Kuzuya T; Katano Y; Kumada T; Toyoda H; Nakano I; Hirooka Y; Itoh A; Ishigami M; Hayashi K; Honda T; Goto H
J Gastroenterol Hepatol; 2007 Nov; 22(11):1929-35. PubMed ID: 17914972
[TBL] [Abstract][Full Text] [Related]
17. Natural history of chronic hepatitis B REVEALed.
Chen CJ; Yang HI
J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
[TBL] [Abstract][Full Text] [Related]
18. Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced disease.
Yuen MF; Seto WK; Chow DH; Tsui K; Wong DK; Ngai VW; Wong BC; Fung J; Yuen JC; Lai CL
Antivir Ther; 2007; 12(8):1295-303. PubMed ID: 18240869
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B vaccination in children: the Taiwan experience.
Ni YH; Chen DS
Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of hepatitis B virus-related Chronic Hepatitis under protracted nucleos(t)ide analogues.
Niro GA; Ippolito AM; Fontana R; Valvano MR; Gioffreda D; Iacobellis A; Merla A; Durazzo M; Lotti G; Di Mauro L; Andriulli A
J Viral Hepat; 2013 Jul; 20(7):502-9. PubMed ID: 23730844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
